Nothing Special   »   [go: up one dir, main page]

AR128824A1 - Métodos de análisis y cuantificación de variantes polipeptídicas de carga - Google Patents

Métodos de análisis y cuantificación de variantes polipeptídicas de carga

Info

Publication number
AR128824A1
AR128824A1 ARP230100670A ARP230100670A AR128824A1 AR 128824 A1 AR128824 A1 AR 128824A1 AR P230100670 A ARP230100670 A AR P230100670A AR P230100670 A ARP230100670 A AR P230100670A AR 128824 A1 AR128824 A1 AR 128824A1
Authority
AR
Argentina
Prior art keywords
charge variants
quantification
analysis
methods
isoelectric
Prior art date
Application number
ARP230100670A
Other languages
English (en)
Inventor
Nisha Palackal
Kun Lu
Gangadhar Dhulipala
Erica Pyles
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of AR128824A1 publication Critical patent/AR128824A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44795Isoelectric focusing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44713Particularly adapted electric power supply
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • G01N27/44726Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Power Engineering (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para cuantificar las variantes de carga dentro de un analito puede incluir la introducción de un buffer de muestra que comprende el analito en un capilar, la separación de las variantes de carga dentro del buffer de muestra a lo largo de un gradiente isoeléctrico, la incubación del capilar en un anticuerpo de detección, la cuantificación de una abundancia relativa de una variante de carga en base a una señal que corresponde al anticuerpo de detección. El método puede incluir además la generación de un electroferograma, en donde el electroferograma incluye un gráfico de una intensidad de una señal generada por una molécula reportera frente a un punto isoeléctrico a lo largo del gradiente isoeléctrico donde se detectó la señal.
ARP230100670A 2022-03-18 2023-03-17 Métodos de análisis y cuantificación de variantes polipeptídicas de carga AR128824A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263269595P 2022-03-18 2022-03-18

Publications (1)

Publication Number Publication Date
AR128824A1 true AR128824A1 (es) 2024-06-19

Family

ID=86272286

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230100670A AR128824A1 (es) 2022-03-18 2023-03-17 Métodos de análisis y cuantificación de variantes polipeptídicas de carga

Country Status (9)

Country Link
US (1) US20230296559A1 (es)
EP (1) EP4493921A1 (es)
KR (1) KR20240164561A (es)
CN (1) CN119137473A (es)
AR (1) AR128824A1 (es)
AU (1) AU2023233590A1 (es)
IL (1) IL315548A (es)
TW (1) TW202346856A (es)
WO (1) WO2023177836A1 (es)

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0535162T3 (da) * 1990-06-21 1995-06-12 Axis Biochemicals As Analyse for analytvarianter
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
SG106672A1 (en) 2002-03-08 2004-10-29 Asml Netherlands Bv Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method
BRPI0712224B8 (pt) 2006-06-02 2021-05-25 Regeneron Pharma anticorpos de alta afinidade para o receptor de il-6 humano e composições farmacêuticas
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
KR101561020B1 (ko) 2007-07-31 2015-10-26 리제너론 파아마슈티컬스, 인크. 사람 cd20에 대한 사람 항체 및 이의 사용 방법
JO3672B1 (ar) 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
JO3340B1 (ar) 2010-05-26 2019-03-13 Regeneron Pharma مضادات حيوية لـعامل تمايز النمو 8 البشري
AR083044A1 (es) 2010-09-27 2013-01-30 Regeneron Pharma Anticuerpos anti-cd48 y usos de los mismos
EP2624865B1 (en) 2010-10-06 2018-08-01 Regeneron Pharmaceuticals, Inc. Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
JO3756B1 (ar) 2010-11-23 2021-01-31 Regeneron Pharma اجسام مضادة بشرية لمستقبلات الجلوكاجون
JO3412B1 (ar) 2011-06-17 2019-10-20 Regeneron Pharma أجسام مضادة ل angptl3 واستخداماتها
US8871209B2 (en) 2011-11-14 2014-10-28 Regeneron Pharmaceuticals, Inc. Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
KR102063028B1 (ko) 2012-01-23 2020-01-07 리제너론 파아마슈티컬스, 인크. 항-ang2 항체를 함유하는 안정화된 제형
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
TW201843172A (zh) 2012-06-25 2018-12-16 美商再生元醫藥公司 抗-egfr抗體及其用途
MX363213B (es) 2012-08-13 2019-03-15 Regeneron Pharma Anticuerpos anti-pcsk9 con características de unión dependientes del ph.
JOP20200236A1 (ar) 2012-09-21 2017-06-16 Regeneron Pharma الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
JO3405B1 (ar) 2013-01-09 2019-10-20 Regeneron Pharma الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
WO2014152195A1 (en) 2013-03-15 2014-09-25 Regeneron Pharmaceuticals, Inc. Il-33 antagonists and uses thereof
TWI641620B (zh) 2013-08-21 2018-11-21 再生元醫藥公司 抗-prlr抗體及其用途
TWI681969B (zh) 2014-01-23 2020-01-11 美商再生元醫藥公司 針對pd-1的人類抗體
TWI680138B (zh) 2014-01-23 2019-12-21 美商再生元醫藥公司 抗pd-l1之人類抗體
SI3126388T1 (sl) 2014-03-11 2019-08-30 Regeneron Pharmaceuticals, Inc. Protitelesa ANTI-EGFRVIII in njihova uporaba
TWI754319B (zh) 2014-03-19 2022-02-01 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
RU2713327C2 (ru) 2014-05-05 2020-02-04 Регенерон Фармасьютикалз, Инк. Гуманизированные животные по с5 и с3
WO2016044337A1 (en) 2014-09-16 2016-03-24 Regeneron Pharmaceuticals, Inc. Anti-glucagon antibodies and uses thereof
JP7399845B2 (ja) * 2017-08-18 2023-12-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 試料マトリックスにおいてタンパク質変異体を分析するための画像キャピラリー等電点電気泳動法
US11782023B2 (en) * 2018-12-19 2023-10-10 Regeneron Pharmaceuticals, Inc. Ce-western applications for antibody development
JP2022519246A (ja) * 2019-01-31 2022-03-22 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗体電荷不均一性についてのネイティブマイクロ流体ce-ms解析法
EP3973297A1 (en) * 2019-05-23 2022-03-30 Regeneron Pharmaceuticals, Inc. Characterization of domain-specific charge variants of antibodies

Also Published As

Publication number Publication date
AU2023233590A1 (en) 2024-10-17
EP4493921A1 (en) 2025-01-22
CN119137473A (zh) 2024-12-13
US20230296559A1 (en) 2023-09-21
IL315548A (en) 2024-11-01
WO2023177836A1 (en) 2023-09-21
KR20240164561A (ko) 2024-11-19
TW202346856A (zh) 2023-12-01

Similar Documents

Publication Publication Date Title
WO2020123319A3 (en) Methods of using master / copy arrays for spatial detection
EP4372383A3 (en) Methods and systems for protein identification
CA2798517A1 (en) Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments
CY1113490T1 (el) Μεθοδος διαχωρισμου πρωτεϊνων με τριχοειδη ηλεκτροφορηση και συνθεσεις ρυθμιστικου για τριχοειδη ηλεκτροφορηση
Zhu et al. Capillary zone electrophoresis tandem mass spectrometry detects low concentration host cell impurities in monoclonal antibodies
MX2015013596A (es) Metodos, dispositivos y sistemas para analisis de muestras.
Nagata et al. Microchip electrophoretic protein separation using electroosmotic flow induced by dynamic sodium dodecyl sulfate‐coating of uncoated plastic chips
WO2002057737A3 (fr) Procede de separation de proteines par electrophorese capillaire et compositions de tampon pour electrophorese capillaire
Khurana et al. Effects of carbon dioxide on peak mode isotachophoresis: Simultaneous preconcentration and separation
AR128824A1 (es) Métodos de análisis y cuantificación de variantes polipeptídicas de carga
US9373486B2 (en) Species detection using mass spectrometry
Winnik et al. Analysis of proteins using DIGE and MALDI mass spectrometry
Szyrwiel et al. Speedy-PASEF: Analytical flow rate chromatography and trapped ion mobility for deep high-throughput proteomics
CO2021007715A2 (es) Metodos para detectar neutralizando anticuerpos a hormona paratiroidea (pth) y analogo de peptido relacionado con hormona paratiroidea (pthrp)
EP4253950A3 (en) Ce-western applications for antibody development
Klenø et al. MALDI MS peptide mapping performance by in-gel digestion on a probe with prestructured sample supports
Feret et al. Protein profiling using two‐dimensional difference gel electrophoresis (2‐D DIGE)
Goto et al. Development of an automated direct blotting electrophoresis system for bioanalytical applications
EA202190355A1 (ru) Применение жх-мс/мс для количественного определения белковых биомаркеров
DE60321449D1 (de) Verfahren zur zweidimensionalen konformationsabhängigen trennung nichtzirkulärer nukleinsäuren
BR112022003113A2 (pt) Método e aparelho para armazenamento de informações de movimento
WO2014156293A1 (ja) 分析方法
ATE426173T1 (de) Proteinanalyseverfahren
Galanopoulos Developing novel workflows for improved bottom-up, top-down and middle-down mass spectrometry analysis of proteins
CN108445069A (zh) 带有微阵列固定化pH梯度柱的等电聚焦电泳芯片及方法